CorVita Health is pleased to offer a comprehensive clinical genetics consultation for management of sudden cardiac death, cardiomyopathy, and cardiac electronic implantable device clinical decision making.
Specific areas of interest include the following clinical diseases, syndromes and conditions:
- Cardiomyopathies- Dilated, Hypertrophic, Mixed Conditions, Amyloidosis, Arrhythmogenic Ventricular Cardiomyopathies (ARVC), Long QT Syndromes, Brugada Syndromes, Short QT syndromes, Marfan Syndromes, Mitral Valve Prolapse, Catecholamine Polymorphic Ventricular Tachycardia (CPVT), Mitochondrial disorders,
- Arrhythmic Conditions- congenital heart block, Sarcoidosis, TTN (TITIN DISORDERS), LMNA disorders, repetitive monomorphic ventricular tachycardia, idiopathic ventricular fibrillation and atrial fibrillation.
- Familial Hyperlipidemia
- Cardiac tumors
Phased Approach to Consultation:
Phase I: Phenotypic (known abnormality) presentation of index patient.
Phase II: Focused Genetic Testing
Phase III: Testing result applied to the clinical condition(s).
Phase IV: Appropriate counseling of the patient based on abnormal genetic finding with clinical
management.
Phase V: Family assessments and testing recommendations.
Phase VI: Continuing outpatient clinical care.